HK Stock MarketDetailed Quotes

02315 BIOCYTOGEN-B

Watchlist
  • 8.450
  • -0.110-1.29%
Market Closed Dec 27 16:08 CST
3.37BMarket Cap-12.63P/E (TTM)

BIOCYTOGEN-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
(FY)Dec 31, 2019
Assets
Current assets
Inventory
-67.70%4.64M
-60.14%7.42M
-47.20%14.35M
22.88%18.6M
--27.18M
89.72%15.14M
159.68%7.98M
--3.07M
Accounts receivable
60.99%184.63M
32.23%142.38M
15.79%114.68M
4.46%107.68M
--99.04M
53.35%103.09M
85.49%67.23M
--36.24M
Advance deposits and other receivables
-22.03%24.72M
-35.39%26.06M
-66.08%31.71M
-49.35%40.33M
--93.46M
66.83%79.62M
118.94%47.73M
--21.8M
Cash and equivalents
-25.38%411.24M
-33.35%417.66M
58.82%551.09M
34.34%626.62M
--347M
-37.81%466.45M
204.42%750.04M
--246.38M
Special items of current assets
4.91%132.31M
2.71%121.05M
1.70%126.11M
7.20%117.86M
--124M
47.26%109.94M
43.13%74.66M
--52.16M
Total current assets
-9.49%766.14M
-21.35%723.05M
22.56%846.52M
5.15%919.3M
--690.68M
-23.82%874.24M
70.87%1.15B
--671.64M
Non-current assets
Property, plant and equipment
-12.36%1.39B
-9.27%1.45B
10.23%1.59B
14.96%1.6B
--1.44B
22.49%1.39B
112.88%1.14B
--533.45M
Associated company interest
-7.30%179.29M
-4.83%188.38M
28,095.19%193.42M
1,943.82%197.94M
--686K
-3.99%9.69M
--10.09M
----
Intangible assets
-23.54%24.44M
-8.23%28.13M
457.15%31.97M
406.23%30.65M
--5.74M
149.38%6.06M
15.07%2.43M
--2.11M
Other illiquid assets
24.12%67.45M
11.66%59.03M
61.55%54.34M
141.82%52.86M
--33.64M
-28.97%21.86M
101.77%30.77M
--15.25M
Total non-current assets
-10.97%1.67B
-8.20%1.73B
26.11%1.87B
31.64%1.88B
--1.48B
21.18%1.43B
114.03%1.18B
--550.81M
Total assets
-10.51%2.43B
-12.52%2.45B
24.98%2.72B
21.58%2.8B
--2.17B
-1.02%2.3B
90.32%2.33B
--1.22B
Liabilities
Current liabilities
Accounts payable
-5.69%117.78M
19.87%175.23M
2.94%124.88M
42.71%146.19M
--121.32M
16.94%102.44M
399.77%87.6M
--17.53M
Tax payable
71.00%2.09M
33.33%1.07M
--1.22M
--804K
----
----
----
----
Other payables and accrued expenses
-37.42%132.85M
-44.22%128.89M
-8.83%212.29M
-9.61%231.07M
--232.86M
42.62%255.64M
98.24%179.25M
--90.42M
Bank loans and overdrafts
22.69%223.61M
39.61%176.84M
218.19%182.26M
--126.67M
--57.28M
----
----
----
Financial lease liabilities-current liabilities
-51.45%23.08M
-41.33%26.36M
59.80%47.54M
67.07%44.94M
--29.75M
90.68%26.9M
500.00%14.11M
--2.35M
Special items of current liabilities
----
----
----
----
----
----
----
--1.26B
Total current liabilities
-11.85%572.61M
-4.69%577.62M
18.98%649.56M
35.71%606.05M
--545.95M
35.95%446.56M
-76.70%328.47M
--1.41B
Net current assets
-1.74%193.54M
-53.57%145.43M
36.08%196.96M
-26.76%313.25M
--144.73M
-47.79%427.68M
210.97%819.17M
---738.21M
Total assets less current liabilities
-10.09%1.86B
-14.68%1.87B
27.00%2.07B
18.19%2.19B
--1.63B
-7.10%1.86B
1,166.16%2B
---187.41M
Non-current liabilities
Long-term bank loan
227.31%171.87M
233.34%173.91M
--52.51M
--52.17M
----
----
----
----
Long-term accounts payable
-9.78%699.69M
-8.16%651.48M
60.87%775.53M
58.14%709.36M
--482.07M
17.15%448.55M
73.40%382.88M
--220.81M
Financial lease liabilities-non-current liabilities
-16.11%156.69M
-12.79%167.01M
226.13%186.78M
204.45%191.51M
--57.27M
-5.85%62.9M
1,053.92%66.81M
--5.79M
Deferred tax liability
--1.41M
--1.9M
----
----
----
----
----
----
Deferred income-non-current liabilities
-3.14%85.72M
-3.18%87.07M
-3.13%88.5M
-3.09%89.93M
--91.37M
2.97%92.8M
-1.07%90.12M
--91.1M
Total non-current liabilities
1.09%1.12B
3.68%1.08B
74.93%1.1B
72.60%1.04B
--630.71M
11.94%604.25M
69.91%539.81M
--317.7M
Total liabilities
-3.70%1.69B
0.60%1.66B
48.97%1.75B
56.93%1.65B
--1.18B
21.02%1.05B
-49.74%868.28M
--1.73B
Total assets less total liabilities
-22.87%744.24M
-31.32%790.44M
-3.30%964.91M
-8.08%1.15B
--997.86M
-14.15%1.25B
388.70%1.46B
---505.11M
Total equity and non-current liabilities
-10.09%1.86B
-14.68%1.87B
27.00%2.07B
18.19%2.19B
--1.63B
-7.10%1.86B
1,166.16%2B
---187.41M
Equity
Share capital
0.00%399.4M
0.00%399.4M
6.53%399.4M
6.53%399.4M
--374.93M
4.15%374.93M
886.30%360M
--36.5M
Reserve
-39.34%340.29M
-48.25%386.49M
-9.29%560.96M
-14.38%746.87M
--618.38M
-20.22%872.28M
371.67%1.09B
---402.48M
Shareholders' Equity
-22.98%739.69M
-31.44%785.89M
-3.32%960.36M
-8.09%1.15B
--993.31M
-14.19%1.25B
497.13%1.45B
---365.98M
Non-controlling interest
0.00%4.55M
-0.02%4.55M
-0.11%4.55M
-4.45%4.55M
--4.56M
-1.39%4.76M
103.47%4.83M
---139.13M
Total equity
-22.87%744.24M
-31.32%790.44M
-3.30%964.91M
-8.08%1.15B
--997.86M
-14.15%1.25B
388.70%1.46B
---505.11M
Total equity and total liabilities
-10.51%2.43B
-12.52%2.45B
24.98%2.72B
21.58%2.8B
--2.17B
-1.02%2.3B
90.32%2.33B
--1.22B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
Auditor
--
KPMG
--
KPMG
--
KPMG
KPMG
KPMG
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020(FY)Dec 31, 2019
Assets
Current assets
Inventory -67.70%4.64M-60.14%7.42M-47.20%14.35M22.88%18.6M--27.18M89.72%15.14M159.68%7.98M--3.07M
Accounts receivable 60.99%184.63M32.23%142.38M15.79%114.68M4.46%107.68M--99.04M53.35%103.09M85.49%67.23M--36.24M
Advance deposits and other receivables -22.03%24.72M-35.39%26.06M-66.08%31.71M-49.35%40.33M--93.46M66.83%79.62M118.94%47.73M--21.8M
Cash and equivalents -25.38%411.24M-33.35%417.66M58.82%551.09M34.34%626.62M--347M-37.81%466.45M204.42%750.04M--246.38M
Special items of current assets 4.91%132.31M2.71%121.05M1.70%126.11M7.20%117.86M--124M47.26%109.94M43.13%74.66M--52.16M
Total current assets -9.49%766.14M-21.35%723.05M22.56%846.52M5.15%919.3M--690.68M-23.82%874.24M70.87%1.15B--671.64M
Non-current assets
Property, plant and equipment -12.36%1.39B-9.27%1.45B10.23%1.59B14.96%1.6B--1.44B22.49%1.39B112.88%1.14B--533.45M
Associated company interest -7.30%179.29M-4.83%188.38M28,095.19%193.42M1,943.82%197.94M--686K-3.99%9.69M--10.09M----
Intangible assets -23.54%24.44M-8.23%28.13M457.15%31.97M406.23%30.65M--5.74M149.38%6.06M15.07%2.43M--2.11M
Other illiquid assets 24.12%67.45M11.66%59.03M61.55%54.34M141.82%52.86M--33.64M-28.97%21.86M101.77%30.77M--15.25M
Total non-current assets -10.97%1.67B-8.20%1.73B26.11%1.87B31.64%1.88B--1.48B21.18%1.43B114.03%1.18B--550.81M
Total assets -10.51%2.43B-12.52%2.45B24.98%2.72B21.58%2.8B--2.17B-1.02%2.3B90.32%2.33B--1.22B
Liabilities
Current liabilities
Accounts payable -5.69%117.78M19.87%175.23M2.94%124.88M42.71%146.19M--121.32M16.94%102.44M399.77%87.6M--17.53M
Tax payable 71.00%2.09M33.33%1.07M--1.22M--804K----------------
Other payables and accrued expenses -37.42%132.85M-44.22%128.89M-8.83%212.29M-9.61%231.07M--232.86M42.62%255.64M98.24%179.25M--90.42M
Bank loans and overdrafts 22.69%223.61M39.61%176.84M218.19%182.26M--126.67M--57.28M------------
Financial lease liabilities-current liabilities -51.45%23.08M-41.33%26.36M59.80%47.54M67.07%44.94M--29.75M90.68%26.9M500.00%14.11M--2.35M
Special items of current liabilities ------------------------------1.26B
Total current liabilities -11.85%572.61M-4.69%577.62M18.98%649.56M35.71%606.05M--545.95M35.95%446.56M-76.70%328.47M--1.41B
Net current assets -1.74%193.54M-53.57%145.43M36.08%196.96M-26.76%313.25M--144.73M-47.79%427.68M210.97%819.17M---738.21M
Total assets less current liabilities -10.09%1.86B-14.68%1.87B27.00%2.07B18.19%2.19B--1.63B-7.10%1.86B1,166.16%2B---187.41M
Non-current liabilities
Long-term bank loan 227.31%171.87M233.34%173.91M--52.51M--52.17M----------------
Long-term accounts payable -9.78%699.69M-8.16%651.48M60.87%775.53M58.14%709.36M--482.07M17.15%448.55M73.40%382.88M--220.81M
Financial lease liabilities-non-current liabilities -16.11%156.69M-12.79%167.01M226.13%186.78M204.45%191.51M--57.27M-5.85%62.9M1,053.92%66.81M--5.79M
Deferred tax liability --1.41M--1.9M------------------------
Deferred income-non-current liabilities -3.14%85.72M-3.18%87.07M-3.13%88.5M-3.09%89.93M--91.37M2.97%92.8M-1.07%90.12M--91.1M
Total non-current liabilities 1.09%1.12B3.68%1.08B74.93%1.1B72.60%1.04B--630.71M11.94%604.25M69.91%539.81M--317.7M
Total liabilities -3.70%1.69B0.60%1.66B48.97%1.75B56.93%1.65B--1.18B21.02%1.05B-49.74%868.28M--1.73B
Total assets less total liabilities -22.87%744.24M-31.32%790.44M-3.30%964.91M-8.08%1.15B--997.86M-14.15%1.25B388.70%1.46B---505.11M
Total equity and non-current liabilities -10.09%1.86B-14.68%1.87B27.00%2.07B18.19%2.19B--1.63B-7.10%1.86B1,166.16%2B---187.41M
Equity
Share capital 0.00%399.4M0.00%399.4M6.53%399.4M6.53%399.4M--374.93M4.15%374.93M886.30%360M--36.5M
Reserve -39.34%340.29M-48.25%386.49M-9.29%560.96M-14.38%746.87M--618.38M-20.22%872.28M371.67%1.09B---402.48M
Shareholders' Equity -22.98%739.69M-31.44%785.89M-3.32%960.36M-8.09%1.15B--993.31M-14.19%1.25B497.13%1.45B---365.98M
Non-controlling interest 0.00%4.55M-0.02%4.55M-0.11%4.55M-4.45%4.55M--4.56M-1.39%4.76M103.47%4.83M---139.13M
Total equity -22.87%744.24M-31.32%790.44M-3.30%964.91M-8.08%1.15B--997.86M-14.15%1.25B388.70%1.46B---505.11M
Total equity and total liabilities -10.51%2.43B-12.52%2.45B24.98%2.72B21.58%2.8B--2.17B-1.02%2.3B90.32%2.33B--1.22B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified OpinionUnqualified OpinionUnqualified Opinion
Auditor --KPMG--KPMG--KPMGKPMGKPMG

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
HK
Overall
Symbol
Price
% Chg

No Data

Investment Theme Pharmaceutical Companies
Pharmaceutical Companies
Intraday-0.61%